Transcatheter arterial chemoembolization (TACE) combined with γ-knife compared to TACE or γ-knife alone for hepatocellular carcinoma

Medicine
Yeyu CaiZhu Chen

Abstract

To compare the clinical efficacies and adverse reactions between transcatheter arterial chemoembolization (TACE), γ-ray 3-dimensional fractionated stereotactic conformal radiotherapy (FSCR), and TACE combined with FSCR for primary hepatocellular carcinoma.The study was approved by the Institutional Review Board, and informed consent was waived due to the retrospective study design. About 121 patients met the inclusion criteria and were included in this study, from March 2008 to January 2010, in the Second Xiangya Hospital. Forty-six patients underwent TACE alone, 36 patients underwent γ-knife alone, and 39 were treated by γ-knife combined with TACE. Short-term effects, overall survival rates, adverse reactions, and survival times were compared between the 3 treatment groups.Short-term effects were observed in 41.3% of the TACE group, 33.3% of the γ-knife group, and 64.1% of the TACE combined γ-knife group (P = .020). Overall survival rates at 6,12, 18, and 24 months were 50%, 34.8%, 28.3%, and 21.7% for the TACE group, 36.1%, 30.6%, 16.7%, and 11.1% for γ-knife group, and 84.6%, 71.8%, 61.5%, and 30.8% for TACE combined γ-knife group, respectively. The differences in the overall survival rates at 6, 12, and 18 months between th...Continue Reading

References

Oct 13, 1999·Seminars in Liver Disease·F X BoschJ Borràs
Oct 2, 2002·Journal of Vascular and Interventional Radiology : JVIR·Adrian M Di Bisceglie
Dec 12, 2003·Lancet·Josep M LlovetJordi Bruix
Oct 28, 2004·Gastroenterology·Jordi BruixJosep M Llovet
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Laura A DawsonKristy K Brock
Jul 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Tracey E SchefterLaurie E Gaspar
Oct 18, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Hollins P ClarkRonald J Zagoria
Jun 29, 2007·Nature Clinical Practice. Oncology·Myron SchwartzManousos Konstadoulakis
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Sep 2, 2009·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Sung Wook Shin

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
irradiate

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.